Publications

5674 Results

Results of telomerase activity measurements from live circulating tumor cells captured on a slot microfilter in a phase III SWOG-coordinated prostate cancer trial (S0421)

Authors
A Goldkorn;B Ely;DI Quinn;C Tangen;Y-C Tai;P Twardowski;P Van Veldhuizen;N Agarwal;M Carducci;JP Monk;MG Garzotto;PC Mack;PN Lara;CS Higano;M Hussain;N Vogelzang;RJ Cote;IM Thompson
Journal / Conference
J Clin Oncol 30 (suppl; abstr 4663); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster presentation;
Year
2012
Research Committee(s)
Genitourinary
Study Number(s)
S0421

A phase II study of PXD101 (belinostat) in relapsed and refractory aggressive b-cell lymphomas (rel/ref ABCL): SWOG S0520

Authors
D Perksy;S Bernstein;B Goldman;LM Rimsza;RI Fisher;TP Miller
Journal / Conference
J Clin Oncol 30 (suppl; abstr e18536);American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), publication only;
Year
2012
Research Committee(s)
Lymphoma
Study Number(s)
S0520

SWOG S0533: A pilot trial of cisplatin (C)/Etoposide (E)/radiotherapy (RT) followed by consolidation docetaxel (LD) and bevacizumab (B) (NSC-704865) in three cohorts of patients (pts) with inoperable locally advanced stage III non-small cell lung cancer (NSCLC)

Authors
A Wozniak;J Moon;CR Thomas;K Kelly;PC Mack;LE Gaspar;D Raben;KJ Pandya;DR Gandara
Journal / Conference
J Clin Oncol 30 (suppl; abstr 7018);American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster discussion
Year
2012
Research Committee(s)
Lung
Study Number(s)
S0533

Molecular marker analysis of SWOG S0636, a phase II trial of erlotinib and bevacizumab in never-smokers with advanced NSCLC

Authors
PC Mack;J Moon;H West;W Franklin;M Varella-Garcia;M Wynes;A Wozniak;M Redman;F Hirsch;D Gandara
Journal / Conference
J Clin Oncol 30, 2012 (suppl; abstr 7552); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster presentation;
Year
2012
Research Committee(s)
Lung
Study Number(s)
S0636

SWOG S0635 and S0636: Phase II Trials of Erlotinib (OSI-774)(E) and Bevacizumab (B) in Advanced (Adv) Bronchioloalveolar Carcinoma (BAC) and Adenocarcinoma with BAC Features (adenoBAC), or in Never-Smokers with Primary Adv NSCLC Adenocarcinoma (adenoCa)

Authors
H West;J Moon;F Hirsch;PC Mack;A Wozniak;D Lau;L Fehrenbacher;M Bury;M Redman;D Gandara
Journal / Conference
J Clin Oncol 30 (suppl; abstr 7517); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster discussion;
Year
2012
Research Committee(s)
Lung
Study Number(s)
S0635, S0636

A Phase II Trial of Azacitidine (NSC-102816) and Gemtuzumab Ozogamicin (NSC-720568) as Induction and Post-Remission Therapy in Patients of Age 60 and Older with Previously Untreated Non-M3 Acute Myeloid Leukemia (SWOG S0703): Report on the Good Risk Patients

Authors
S Nand;H Gundacker;JE Godwin;C Willman;T Norwood;H Erba;D Howard;S Coutre;M Othus;F Appelbaum
Journal / Conference
J Clin Oncol 30 (suppl; abstr 6502); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), oral presentation;
Year
2012
Research Committee(s)
Leukemia
Study Number(s)
S0703

Phase I Pharmacokinetic Study of Dasatinib (BMC-354825) in Patients with Advanced Malignancies and Varying Levels of Liver Dysfunction: S0711, a SWOG Early Therapeutics Committee Study

Authors
J Sarantopoulos;A Hoering;T Synold;D Mahalingam;D Wang;HJ Lenz;P O'Rourke;R Sexton;P Van Veldhuizen;M Mita;L Wong;A Mita;A El-Khoueiry;V Chung;D Gandara;S Tejwan;C Takimoto;P Ivy;R Kurzrock
Journal / Conference
J Clin Oncol 30 (suppl; abstr 3078);American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster presentation;
Year
2012
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S0711

SWOG S0715: Randomized Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy

Authors
DL Hershman;J Unger;K Crew;C Moinpour;L Minasian;L Hansen;D Lew;P O'Kane;J Wade;S Wong;G Hortobagyi;F Meyskens;K Albain
Journal / Conference
Journal of Clinical Oncology 30 (suppl; abstr 9018);American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster discussion (DH unsuccessfully appealed for oral);
Year
2012
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S0715

SWOG 0722: A phase II study of mTOR inhibitor everolimus (RAD001) in malignant pleural mesothelioma (MPM)

Authors
L Garland;S-H Ou;J Moon;PC Mack;J Testa;A Tsao;A Wozniak;D Gandara
Journal / Conference
J Clin Oncol 30 (suppl; abstr 7083); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster presentation;
Year
2012
Research Committee(s)
Lung
Study Number(s)
S0722

Dual blockade of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor-1 (IGF-1R) signaling in metastatic pancreatic cancer: Phase I/randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotinib

Authors
PA Philip;B Goldman;R Ramanathan;HJ Lenz;A Lowy;R Whitehead;S Iqbal;R Gaur;J Benedetti;CD Blanke
Journal / Conference
J Clin Oncol 30 (suppl; abstr 4019);American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster discussion;
Year
2012
Research Committee(s)
Gastrointestinal
Study Number(s)
S0727